Lv1
30 积分 2026-02-27 加入
Cutaneous Toxicities of Small Molecules in Targeted Cancer Therapy Part I – Mechanisms of Toxicity
14小时前
待确认
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已关闭
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Comparison of Breast Cancer Recurrence and Outcome Patterns Between Patients Treated From 1986 to 1992 and From 2004 to 2008
2个月前
已完结
Systemic treatment of patients with early breast cancer: recent updates and state of the art
2个月前
已完结
Immunotherapy in triple-negative breast cancer: From molecular mechanisms to precision medicine—overcoming resistance and optimizing clinical outcomes
5个月前
已关闭
皖公网安备34019202002308
